Company intelligence / Profile preview

Coast BioVentures

Del Mar, California, United States

Ownership: Private
Development stage: Other

Overview

Coast BioVentures is a private life sciences-focused venture capital firm rather than a drug-development operating company. Founded in 2021, the firm appears to focus on seed through Series A investments in Southern California and broader life science sectors including therapeutics, companion diagnostics, precision medicine, CRO/CDMO services, and life science tools. Publicly available descriptions consistently characterize it as an emerging fund led by David H. Crean. Because it is an investment manager, it does not appear to have an internal therapeutic pipeline, product candidates, or clinical-stage assets of its own.

Industry: Investors

Beyond the preview

Go deeper on Coast BioVentures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coast BioVentures.

Explore the full profile